financetom
Business
financetom
/
Business
/
Blue Foundry Bancorp To Merge With Fulton Financial In $243 Million Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blue Foundry Bancorp To Merge With Fulton Financial In $243 Million Deal
Nov 24, 2025 9:48 AM

Blue Foundry Bancorp ( BLFY ) stock soared Monday after the company disclosed a merger deal with Fulton Financial Corporation ( FULT ) for roughly $243 million.

Details

As per the deal, Fulton will acquire Blue Foundry in an all-stock deal.

Each Blue Foundry share will be exchanged for 0.6500 Fulton shares. Based on Fulton’s November 21, 2025, share price of $17.96, the transaction is valued at $11.67 per Blue Foundry share.

As part of the deal, Fulton will contribute $1.5 million to the Fulton Forward Foundation to fund impact grants for nonprofit community organizations in New Jersey.

Synergies

The deal strengthens Fulton’s presence in the high-growth northern New Jersey market.

The merger is expected to boost first full-year earnings by over 5%, be immediately accretive to tangible book value per share, and remain neutral to regulatory capital ratios at closing.

Both Fulton’s and Blue Foundry’s boards have unanimously approved the merger, which is expected to close in the second quarter of 2026, pending regulatory and shareholder approvals.

Post closure, Blue Foundry Bank will merge into Fulton Bank, N.A., with Fulton Bank as the surviving entity.

Management Commentary

Curtis J. Myers, Fulton Chairman and CEO, said, “The combination of our companies creates an opportunity to leverage Fulton’s robust banking services and provide greater convenience and innovative solutions to an expanded customer base, with a continued focus on supporting our local communities.”

“The expansion in northern New Jersey aligns with our strategy of growing in our local markets and positions us well to drive organic growth across our commercial, consumer, wealth advisory and mortgage businesses.”

As of September 30, Fulton’s cash and due from banks stood at $307.3 million.

Price Action: BLFY shares were trading higher by 39.33% to $11.03 at last check Monday.

Read Next:

Alibaba Q2 Preview: Qwen’s 10 Million Milestone Highlights’ Historic Opportunities’ In AI, Cloud

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved